Clinical validation of deep learning algorithms for radiotherapy targeting of non-small-cell lung cancer: an observational study
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Artificial intelligence (AI) and deep learning have shown great potential in streamlining clinical tasks. However, most studies remain confined to in silico validation in small internal cohorts, without external validation or data on real-world clinical utility. We developed a strategy for the clinical validation of deep learning models for segmenting primary non-small-cell lung cancer (NSCLC) tumours and involved lymph nodes in CT images, which is a time-intensive step in radiation treatment planning, with large variability among experts. METHODS: In this observational study, CT images and segmentations were collected from eight internal and external sources from the USA, the Netherlands, Canada, and China, with patients from the Maastro and Harvard-RT1 datasets used for model discovery (segmented by a single expert). Validation consisted of interobserver and intraobserver benchmarking, primary validation, functional validation, and end-user testing on the following datasets: multi-delineation, Harvard-RT1, Harvard-RT2, RTOG-0617, NSCLC-radiogenomics, Lung-PET-CT-Dx, RIDER, and thorax phantom. Primary validation consisted of stepwise testing on increasingly external datasets using measures of overlap including volumetric dice (VD) and surface dice (SD). Functional validation explored dosimetric effect, model failure modes, test-retest stability, and accuracy. End-user testing with eight experts assessed automated segmentations in a simulated clinical setting. FINDINGS: We included 2208 patients imaged between 2001 and 2015, with 787 patients used for model discovery and 1421 for model validation, including 28 patients for end-user testing. Models showed an improvement over the interobserver benchmark (multi-delineation dataset; VD 0·91 [IQR 0·83-0·92], p=0·0062; SD 0·86 [0·71-0·91], p=0·0005), and were within the intraobserver benchmark. For primary validation, AI performance on internal Harvard-RT1 data (segmented by the same expert who segmented the discovery data) was VD 0·83 (IQR 0·76-0·88) and SD 0·79 (0·68-0·88), within the interobserver benchmark. Performance on internal Harvard-RT2 data segmented by other experts was VD 0·70 (0·56-0·80) and SD 0·50 (0·34-0·71). Performance on RTOG-0617 clinical trial data was VD 0·71 (0·60-0·81) and SD 0·47 (0·35-0·59), with similar results on diagnostic radiology datasets NSCLC-radiogenomics and Lung-PET-CT-Dx. Despite these geometric overlap results, models yielded target volumes with equivalent radiation dose coverage to those of experts. We also found non-significant differences between de novo expert and AI-assisted segmentations. AI assistance led to a 65% reduction in segmentation time (5·4 min; p<0·0001) and a 32% reduction in interobserver variability (SD; p=0·013). INTERPRETATION: We present a clinical validation strategy for AI models. We found that in silico geometric segmentation metrics might not correlate with clinical utility of the models. Experts' segmentation style and preference might affect model performance. FUNDING: US National Institutes of Health and EU European Research Council.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation
Isensee, F., Jaeger, P. F., Kohl, S. A. A., Petersen, J., & Maier-Hein, K. H. (2021) · Nature Methods · doi:10.1038/s41592-020-01008-z · Cited by 10,477
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
A guide to deep learning in healthcare
Esteva, A., Robicquet, A., Ramsundar, B., Kuleshov, V., DePristo, M., Chou, K., Cui, C., Corrado, G., Thrun, S., & Dean, J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0316-z · Cited by 5,312
Artificial Intelligence and Human Trust in Healthcare: Focus on Clinicians
Asan, O., Bayrak, A. E., & Choudhury, A. (2020) · Journal of Medical Internet Research · doi:10.2196/15154 · Cited by 825
Cited by
Swanson, K., Wu, E., Zhang, A., Alizadeh, A. A., & Zou, J. (2023) · Cell · doi:10.1016/j.cell.2023.01.035 · Cited by 597
“59 In their study, AI assistance led to a 65% reduction in segmentation time and a 32% reduction in variability between clinicians.”
BackgroundFoundation Model for Cancer Imaging Biomarkers
Pai, S., Bontempi, D., Hadzic, I., Prudente, V., Sokač, M., Chaunzwa, T. L., Bernatz, S., Hosny, A., Mak, R. H., Birkbak, N. J., et al. (2024) · Nature Machine Intelligence · doi:10.1038/s42256-024-00807-9 · Cited by 199
“We used scans from 26 patients from the RIDER dataset 19 , routinely used for test– retest robustness analysis in tumour imaging 19–21 .”
Self-citationHurkmans, C., Bibault, J.-E., Brock, K. K., van Elmpt, W., Feng, M., David Fuller, C., Jereczek-Fossa, B. A., Korreman, S., Landry, G., Madesta, F., et al. (2024) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2024.110345 · Cited by 110
Revolutionizing radiation therapy: the role of AI in clinical practice
Kawamura, M., Kamomae, T., Yanagawa, M., Kamagata, K., Fujita, S., Ueda, D., Matsui, Y., Fushimi, Y., Fujioka, T., Nozaki, T., et al. (2024) · Journal of Radiation Research · doi:10.1093/jrr/rrad090 · Cited by 86
Macheka, S., Ng, P. Y., Ginsburg, O., Hope, A., Sullivan, R., & Aggarwal, A. (2024) · BMJ Oncology · doi:10.1136/bmjonc-2023-000255 · Cited by 45
Metadata
- Authors
- Hosny, A., Bitterman, D. S., Guthier, C. V., Qian, J. M., Roberts, H., Perni, S., Saraf, A., Peng, L. C., Pashtan, I., Ye, Z., Kann, B. H., Kozono, D. E., Christiani, D., Catalano, P. J., Aerts, H. J. W. L., & Mak, R. H.
- Venue
- The Lancet Digital Health
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 4
- Issue
- 9
- Pages
- e657-e666
- ISSN
- 2589-7500 (ISSN-L)
- OpenAlex
- W4292809017
- Cited by
- 74
- References
- 4
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical validation of deep learning algorithms for radiotherapy targeting of non-small-cell lung cancer: an observational study. https://app.cochat.ai/papers/10.1016/s2589-7500(22)00129-7
- The paper
- Hosny, A., Bitterman, D. S., Guthier, C. V., Qian, J. M., Roberts, H., Perni, S., Saraf, A., Peng, L. C., Pashtan, I., Ye, Z., Kann, B. H., Kozono, D. E., Christiani, D., Catalano, P. J., Aerts, H. J. W. L., & Mak, R. H. (2022). Clinical validation of deep learning algorithms for radiotherapy targeting of non-small-cell lung cancer: an observational study. The Lancet Digital Health. https://doi.org/10.1016/s2589-7500(22)00129-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.